Search - tctmd.com

Displaying 121 - 140 of 423

Sort: Relevancy | Date

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Daily News

ILUMIEN I Publicado: La TCO puede Influir en la Estrategia PCI

L.A. McKeown

August 17, 2015

News Daily News

钙化评分为零“保证”了无症状患者 15 年死亡率

August 06, 2015

News Daily News

Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos

August 06, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

News Daily News

RITA 3 Publicado: La Estrategia Invasiva Rutinaria en SCASEST Pierde su Ventaja a los 10 Años

July 30, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

HeartWare launches European trial for next-gen MVAD heart pump

July 20, 2015

News Daily News

Un Meta Análisis Confirma que las PCI Sin Soporte Quirúrgico son Seguras

July 16, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

La Anestesia General Vuelve a Implicarse en Malos Resultados con el Tratamiento Endovascular de los ACV

L.A. McKeown

July 15, 2015

News Daily News

General Anesthesia Again Implicated in Poorer Outcomes With Endovascular Stroke Therapy

L.A. McKeown

July 15, 2015

News Industry News

Cardiovascular Systems Completes Coast Study Enrollment

July 14, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

Una Peor Movilidad es Fuertemente Predictiva de la Mortalidad en Pacientes TAVR

Yael L. Maxwell

July 06, 2015

News Daily News

Poor Mobility Strongly Predicts Mortality in TAVR Patients

Yael L. Maxwell

July 06, 2015

News Industry News

St. Jude Medical Announces Launch of the First International Trial to Compare OCT-Guided Stent Implantation to IVUS or Angiography-Guided PCI

June 30, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Industry News

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

June 08, 2015

Advertisement

ILUMIEN I Published: OCT Can Affect PCI Strategy

ILUMIEN I Publicado: La TCO puede Influir en la Estrategia PCI

钙化评分为零“保证”了无症状患者 15 年死亡率

Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

RITA 3 Publicado: La Estrategia Invasiva Rutinaria en SCASEST Pierde su Ventaja a los 10 Años

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

HeartWare launches European trial for next-gen MVAD heart pump

Un Meta Análisis Confirma que las PCI Sin Soporte Quirúrgico son Seguras

Meta-analysis Confirms Safety of PCI without Surgical Backup

La Anestesia General Vuelve a Implicarse en Malos Resultados con el Tratamiento Endovascular de los ACV

General Anesthesia Again Implicated in Poorer Outcomes With Endovascular Stroke Therapy

Cardiovascular Systems Completes Coast Study Enrollment

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

Una Peor Movilidad es Fuertemente Predictiva de la Mortalidad en Pacientes TAVR

Poor Mobility Strongly Predicts Mortality in TAVR Patients

St. Jude Medical Announces Launch of the First International Trial to Compare OCT-Guided Stent Implantation to IVUS or Angiography-Guided PCI

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content